cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
-
Contact Email
-
Phone
-
Journal Mail Official
-
Editorial Address
-
Location
Kab. sleman,
Daerah istimewa yogyakarta
INDONESIA
Acta Interna : The Journal of Internal Medicine
Published by Universitas Gadjah Mada
ISSN : 2303131X     EISSN : 25415441     DOI : -
Core Subject : Health,
Health Professions Medicine & Pharmacology
The Journal considers any original research that advocates change in, or illuminates, clinical practice. The journal also publishes interesting and informative reviews and opinions pieces on any topics connected with clinical practice. Manuscripts must be solely the work of the author(s) stated, not have been published previously elsewhere, and not be under consideration by another journal. all papers should be written to be clearly understandable to the journal`s readers in a wide range of specialities and countries. Diagrams, figures, and photographs should be used to supplement and enhance the text.
Arjuna Subject : -
Articles 5 Documents
 1 
Search results for , issue " Vol 3, No 1 (2013): Acta Interna The Journal of Internal Medicine" : 5 Documents clear
CORRELATION OF DEPRESSION SYMPTOMS WITH FEMALE SEXUAL FUNCTION INDEX IN FEMALE HEMODIALYSIS PATIENTS Bonendasari, Agni
Acta Interna The Journal of Internal Medicine Vol 3, No 1 (2013): Acta Interna The Journal of Internal Medicine
Publisher : Acta Interna The Journal of Internal Medicine

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

ABSTRACTIntroduction. Hemodialysis patients experience major changes in lifestyle and suffer various physical and emotional symptoms, especially symptoms of depression and sexual dysfunction in more than half of patients. Sexual dysfunction in women is often not identified because of lack of attention, especially by the clinician. Symptoms of depression limit intimacy, and affect sexual arousal and orgasm. Aim : the aim of the study was to determine the correlation between depressive symptoms and female sexual function index (FSFI) in women hemodialysis patients in the Hemodialysis Unit of Dr. Sardjito General Hospital Yogyakarta.Methods. The method of this study was cross-sectional. Research was conducted at the Hemodialysis Unit by Dr. Sardjito General Hospital Yogyakarta from 10 April to 24 April 2012. Result. There were 42 female patients undergone routine hemodialysis who met the criteria. The median age was 49 years old and had undergone hemodialysis for a median duration of 40 months. Conclusion. There was a negative correlation of depression symptoms and female sexual dysfunction with a moderate strength (r = -0.421) and statistical significantly (P <0.05). Age and prolactin had a negative correlation with a moderate strength of FSFI score. HDL levels and menstrual status had a positive correlation with FSFI, with weak and strong correlation respectively. Key Words: Female sexual function index, depression, hemodialysis
MANIFESTATIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS-INDUCED KIDNEY DISORDERS Charisma, Tiwi
Acta Interna The Journal of Internal Medicine Vol 3, No 1 (2013): Acta Interna The Journal of Internal Medicine
Publisher : Acta Interna The Journal of Internal Medicine

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

INTRODUCTIONNon-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed medication.1 The gastrointestinal tract and kidneys are important targets of clinical events associated with the use of NSAIDs.2 Selective COX-2 inhibitors have minimal gastrointestinal side effects. However, the newer NSAIDs also has nephrotoxic effects remain as nonselective NSAIDs.1The kidneys are the major organ for drug excretion, so that the renal arterioles and glomerular capillaries are especially vulnerable to the effects of drugs. 3 The spectrum of NSAID-induced nephrotoxicity includes acute tubular necrosis, acute tubulointerstitial nephritis, glomerulonephritis, renal papillary necrosis, chronic renal failure, salt and water retention, hypertension, and hyperkalemia. 1Among the various clinical complications, the effects on the kidney are probably the most common and severe due to the use of NSAIDs.4 Fifty million US citizens report NSAIDs use, and it has been estimated that 500.000 – 2,5 million people will develop NSAID nephrotoxicity in the US annually. 5 It has been reported that 37% of drug-associated acute renal failure is associated with the use of NSAIDs, and NSAID-induced acute renal failure accounts for 7% of overall cases of acute renal failure. 4This review discusses the NSAIDs, mechanisms and clinical manifestations of NSAID-induced renal impairment and some NSAID options that can be used in patients with renal failure. 
THE ENDOTHELIN-1 LEVEL OF FEMALE TYPE 2 DIABETIC PATIENTS WITH AND WITHOUT MICROANGIOPATHY COMPLICATIONS Mazayyanah, Siti
Acta Interna The Journal of Internal Medicine Vol 3, No 1 (2013): Acta Interna The Journal of Internal Medicine
Publisher : Acta Interna The Journal of Internal Medicine

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background. Chronic complications of diabetes mellitus (DM) include microangiopathy and macroangiopathy. Microangiopathy includes retinopathy, nephropathy and neuropathy, while macroangiopathy includes coronary heart disease, stroke and peripheral arterial disease. When the diagnosis is established in Type 2 Diabetes Mellitus (DM), approximately 25% had suffered non‐proliferative diabetic retinopathy. Within one to three years of non-proliferative retinopathy progresses to proliferative diabetic retinopathy can eventually be leading to retinal detachment, glaucoma and blindness. Diabetic nephropathy occurs in 20‐40% of patients with diabetes mellitus. Diabetic nephropathy is the leading cause of End Stage Renal Disease (ESRD) and is a high risk of Cardiovascular Disease (CVD). Endothelial dysfunction underlies all of this. Markers of endothelial dysfunction endothelin‐1 are assessed in patients with type 2 diabetes with retinopathy or nephropathy and without retinopathy and nephropathy.Aim of the study. The aim of the study is to show the differences between the level of Endothelin-1 on    female patients Type-2 Diabetes Mellitus with retinopathy or nephropathy compared to those without retinopathy and nephropathy.Method and subjects.  This study uses a cross sectional design which was conducted on subjects from outpatient type 2 diabetes mellitus women with retinopathy or nephropathy compared without retinopathy and nephropathy at endocrinology clinic, Dr. Sardjito General Hospital, Yogyakarta. ELISA sandwich’s method was used to measure plasma levels of endothelin‐1 from veins blood. Differences between groups were compared by student’s unpaired t‐test and Mann‐Whitney test (significant when p<0.05). Diabetic retinopathy is enforced through inspection fundoscopy. Diabetic nephropathy is diagnosed by albumin creatinine ratio (ACR) ≥ 30ug/mg.Result. The results showed that there were 52 female subjects with type 2 DM is composed of them 26 (50%) subjects with retinopathy or nephropathy and 26 (50%) subjects without retinopathy and nephropathy. Median age was 54 (44‐59) years. The mean level(s) of endothelin‐1 obtained (was higher) in women with type‐2 diabetes mellitus with retinopathy or nephropathy (was) 19,47 ± 9,94 ng / ml (and) (compared) with no retinopathy and nephropathy (was) 17,64 ± 11,63 ng / ml (with) (although the difference was not statistically significant) p = 0,944.Conclusion. (Endothelin‐1 levels were higher in women with type‐2 diabetes mellitus with retinopathy or nephropathy than without retinopathy and nephropathy, but the difference was not statistically significant.) No significant difference in endothelin-1 level between type 2 diabetic female patients with and without microangiopathy complications). Key words: endothelin‐1, diabetic retinopathy, diabetic nephropathy, type 2 diabetes mellitus. 
TREATMENT PATTERNS OF PATIENTS WITH RHEUMATOID ARTHRITIS ACCORDING TO THE PRESENCE OF RHEUMATOID FACTOR Rajendran, Puvaneswary
Acta Interna The Journal of Internal Medicine Vol 3, No 1 (2013): Acta Interna The Journal of Internal Medicine
Publisher : Acta Interna The Journal of Internal Medicine

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

ABSTRACTBackground: High titer of rheumatoid factor (RF) in the serum of patients with rheumatoid arthritis (RA) is mostly associated with more severe disease and presence of extra-articular features. To choose the best treatment of RA need the combination of science and art. Objective: the aim of the study was to find the comparison of pharmacological treatment patterns in rheumatoid arthritis patients according to the presence of rheumatoid factor in the serum.Method: This study was a retrospective quantitative observational. The data was collected from medical records of new patients with rheumatoid arthritis who came to the appointment at Rheumatology Clinic Dr. Sardjito Hospital, Yogyakarta in 2010.Results: The total of 39 new patients was eligible in this study. A corticosteroid was the most commonly prescribed (93% of the sero-positive and 84% of the sero-negative patients). Disease modifying anti rheumatic drugs (DMARDs) were used in 92% sero-positive and 84% sero-negative patients (p=0.827; df=6). In choosing the DMARDs, Chloroquine was the most commonly prescribed (29% of sero-positive and 44% of sero-negative patients), followed by methotrexate (21% of sero-positive and 24% of sero-negative) and suphasalazine (21% of sero-positive and 0% of sero-negative). Leflunomide, doxycycline and combined DMARDs were some time prescribed. Non steroidal anti-inflammatory drugs (NSAIDs) were used in 64% sero-positive and 68% sero-negative patients. Conclusion: Corticosteroid was the most commonly prescribed drug. There was no difference between the sero-positive and sero-negative of total patients using DMARDs.  Keywords: Rheumatoid arthritis, rheumatoid factor, corticosteroid, diseases modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs.
THE DIFFERENCE OF SERUM CARBOXY-TERMINAL PROPEPTIDE OF PROCOLLAGEN TYPE I (PIP) IN STAGE A, B AND C HEART FAILURE PATIENTS CAUSED BY HYPERTENSION Aini, Nurul
Acta Interna The Journal of Internal Medicine Vol 3, No 1 (2013): Acta Interna The Journal of Internal Medicine
Publisher : Acta Interna The Journal of Internal Medicine

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

ABSTRACTIntroduction. Arterial hypertension affects the heart tissue composition which leads to structural remodeling of the myocardium. The imbalance between synthesis and degradation of type I collagen leading to myocardial fibrosis in a form of type I collagen fiber accumulation in the interstitial and perivascular myocardium. Collagen fiber accumulation reduces relaxation stage, diastolic suction, myocardial stiffness and diastolic dysfunction which affect systolic dysfunction leading to heart failure. Concentration of carboxy-terminal pro peptide of pro collagen type I (PIP) in peripheral blood am a synthesis index of type I collagen in HHD. Thus, the measurement of PIP is useful to monitor myocardial fibrosis stage in heart failure and to determine the therapeutic strategy that aims not only to reduce arterial pressure and left ventricular mass but also to prevent myocardial remodeling.Aim of the study. The aim of the study was to ascertain the difference PIP level in patients with the heart failure stage A, B, and C which are caused by hypertension. The serum concentration of PIP was measured by enzyme immunoassay. This research was a cross sectional research designed for cardiology policlinic’s outpatients at Dr. Sardjito General Hospital Yogyakarta from August 2009 until the calculated sample number is fulfilled. Method. One-way ANOVA was used to analyze the differences between the three groups of heart failure stages after being tested for the normality using Kolmogorov-Smirnov normality test. If the result did not show a normal value, a non-parametric test would be undergone using Kruskal-Wallis test followed by Mann-Whitney U test. The differences considered as significant if p < 0.05 with a confidence interval of 95%.Result. The research was performed in 64 patients heart failure caused by hypertension consisted of 22 stages A, 19 stage B and 23 stage C. PIP mean levels of the group stage B 819.78 ± 91,03 ng/ml was higher compared stage A 808.47± 80.8 ng/ml and PIP mean level stage C 852 ± 55.51 ng/ml was higher compared stage B. The PIP mean levels did not differ statistically significantly (p=0. 317).Conclusion. There were no significant differences in serum level of PIP on the stage heart failure A, B and C. Keywords: Collagen, fibrosis, hypertension, heart failure, carboxy-terminal pro peptide

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2013 2013


Reset
Filter By Issues
All Issue Vol 10, No 2 (2020): Acta Interna The Journal of Internal Medicine Vol 10, No 1 (2020): Acta Interna The Journal of Internal Medicine Vol 9, No 1 (2019): Acta Interna The Journal of Internal Medicine Vol 7, No 1 (2017): Acta Interna The Journal of Internal Medicine Vol 6, No 2 (2016): Acta Interna The Journal of Internal Medicine Vol 6, No 1 (2016): Acta Interna The Journal of Internal Medicine Vol 5, No 1 (2015): Acta Interna The Journal of Internal Medicine Vol 4, No 2 (2014): The Journal of Internal Medicine Vol 4, No 1 (2014): Acta Interna The Journal Of Internal Medicine Vol 4, No 1 (2014): Acta Interna The Journal Of Internal Medicine Vol 3, No 2 (2013): Acta Interna The Journal of Internal Medicine Vol 3, No 2 (2013): Acta Interna The Journal of Internal Medicine Vol 3, No 1 (2013): Acta Interna The Journal of Internal Medicine Vol 3, No 1 (2013): Acta Interna The Journal of Internal Medicine Vol 2, No 2 (2012): Acta Interna The Journal of Internal Medicine Vol 2, No 2 (2012): Acta Interna The Journal of Internal Medicine Vol 2, No 1 (2012): Acta Interna The Journal of Internal Medicine Vol 2, No 1 (2012): Acta Interna The Journal of Internal Medicine Vol 1, No 2 (2011): Acta Interna The Journal of Internal Medicine Vol 1, No 2 (2011): Acta Interna The Journal of Internal Medicine Vol 1, No 1 (2011): Acta Interna The Journal of Internal Medicine Vol 1, No 1 (2011): Acta Interna The Journal of Internal Medicine More Issue